Medartis Holding AG Logo

Medartis Holding AG

MED | SW

Overview

Corporate Details

ISIN(s):
CH0386200239
LEI:
506700VUSP6HG3F28846
Country:
Switzerland
Address:
Hochbergerstr. 60E, 4057 Basel
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Medartis Holding AG is a global medical device company specializing in the development, manufacturing, and distribution of high-precision implants for the surgical fixation of bone fractures. The company provides a comprehensive portfolio of solutions, including titanium screws, plates, and surgical instruments, primarily for osteosynthesis. Its products are used for fractures and corrections in the upper and lower extremities, as well as for craniomaxillofacial surgeries. Medartis serves surgeons, hospitals, and medical centers worldwide, focusing on delivering innovative and technically advanced implants to improve patient outcomes.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Medartis Holding AG. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-19 06:58
Earnings Release
Medartis delivers 15.3% organic sales growth in H1 and lifts sales guidance for…
English 58.8 KB
2025-08-19 02:00
Earnings Release
Medartis delivers 15.3% organic sales growth in H1 and lifts sales guidance for…
English 65.2 KB
2025-08-19 02:00
Earnings Release
Medartis erzielt im ersten Halbjahr ein organisches Umsatzwachstum von 15,3 % u…
German 67.9 KB
2025-07-30 09:59
Regulatory News Service
Medartis 2025 half-year results webcast
English 11.1 KB
2025-07-17 06:59
M&A Activity
Medartis acquires remaining 53% stake in KeriMedical
English 11.8 KB
2025-07-17 02:00
M&A Activity
Medartis acquires remaining 53% stake in KeriMedical
English 15.5 KB
2025-07-17 02:00
M&A Activity
Medartis erwirbt restliche 53 % der Anteile an KeriMedical
German 16.3 KB
2025-03-19 06:59
Earnings Release
Medartis delivers 12% core sales growth in 2024 and improves its core EBITDA ma…
English 54.2 KB
2025-03-18 06:59
Earnings Release
Medartis delivers 12% core sales growth in 2024 and improves its core EBITDA ma…
English 54.2 KB
2025-03-18 01:00
Earnings Release
Medartis delivers 12% core sales growth in 2024 and improves its core EBITDA ma…
English 61.8 KB
2025-03-18 01:00
Earnings Release
Medartis erzielt 2024 ein Kernumsatzwachstum von 12 % und verbessert ihre Kern-…
German 63.2 KB
2024-08-20 07:05
Earnings Release
Medartis reports 13% revenue growth on Group level, driven by strong regional g…
English 51.0 KB
2024-08-20 02:00
Earnings Release
Medartis reports 13% revenue growth on Group level, driven by strong regional g…
English 45.2 KB
2024-08-20 02:00
Earnings Release
Medartis verzeichnet ein Umsatzwachstum von 13% auf Gruppenebene, angetrieben d…
German 48.8 KB
2024-07-09 06:59
Board/Management Information
Basel, 9th July 2024 Matthias Schupp appointed as CEO of Medartis
English 10.2 KB

Automate Your Workflow. Get a real-time feed of all Medartis Holding AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Medartis Holding AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-04-25 N/A Non-Executive member Buy None 176,411.02 CHF
2025-04-10 N/A Non-Executive member Buy None 37,500.00 CHF
2025-04-08 N/A Non-Executive member Buy None 375,000.00 CHF
2024-12-30 N/A Non-Executive member Buy None 4,999,956.00 CHF
2024-12-20 N/A Executive member Buy None 5,120.00 CHF
2024-12-19 N/A Executive member Buy None 5,300.00 CHF
2024-12-17 N/A Executive member Buy None 16,200.00 CHF
2024-12-16 N/A Executive member Buy None 2,214.00 CHF
2024-12-12 N/A Executive member Buy None 1,188.00 CHF
2024-12-11 N/A Executive member Buy None 72,795.60 CHF

Peer Companies

Company Country Ticker View
ScandiDos AB Logo
Develops quality assurance hardware and software for safe, precise cancer radiation therapy globally.
Sweden SDOS
Scandinavian ChemoTech AB Logo
Develops electroporation tech to enhance chemotherapy for cancer, targeting Asia & the Middle East.
Sweden CMOTEC
Scandinavian Real Heart AB Logo
Develops an implantable Total Artificial Heart for patients with life-threatening heart failure.
Sweden HEART
Schott Pharma Logo
Drug containment & delivery systems (syringes, vials) for the global pharma/biotech industry.
Germany 1SXP
Scope Fluidics S.A. Logo
Biotech venture builder creating microfluidic diagnostic systems for healthcare.
Poland SCP
Sedana Medical Logo
Develops inhaled sedation technology for mechanically ventilated patients in intensive care.
Sweden SEDANA
Sequana Medical N.V. Logo
Implantable pump system treats fluid overload in liver disease, heart failure, and cancer.
Belgium SEQUA
Slavej AD Logo
Provider of prosthetics, orthotics, and mobility aids for people with physical disabilities.
North Macedonia SLAV
S.M.A.I.O Logo
Provides integrated software, implants, and instruments for enhanced control in spinal surgery.
France ALSMA
Smith & Nephew PLC Logo
Global medical tech for tissue repair: orthopaedics, sports medicine, & advanced wound care.
United Kingdom NPWA